insights_auto
Why is KLRS down 5.26%?
Dive Deeperchevron_right
KLRS:NASDAQ
Kalaris Therapeutics Inc
$2.70
arrow_downward
-5.26%(-0.15) 1D
$2.70
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 2, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KLRS...
Open
$2.90
High
$2.90
Low
$2.51
Mkt. cap
64.27M
Avg. vol.
64.48K
Volume
235.90K
52-wk high
$11.88
52-wk low
$2.51
EPS
-$2.09
Beta
0.42
Shares outstanding
23.80M
No. of employees
20
Open
$2.90
High
$2.90
Low
$2.51
Mkt. cap
64.27M
Avg. vol.
64.48K
Volume
235.90K
52-wk high
$11.88
52-wk low
$2.51
EPS
-$2.09
Beta
0.42
Shares outstanding
23.80M
No. of employees
20
News stories
From web sources and news partners
The Motley Fool
·
25 minutes ago
4 Stocks Delivered About Half of the S&P 500's Gain This Year
TradingView
·
6 hours ago
Nasdaq rises for the week as Lumentum leads gains
U.S. Global Investors
·
6 hours ago
Gold Stumbled in September, but Gold Miners Beat Every Sector in the S&P 500
marketscreener.com
·
10 hours ago
Dow's laggard, Nike disappoints again with sales and guidance
About Kalaris Therapeutics Inc
CEO-
Employees20
Founded2019
HeadquartersBerkeley Heights, New Jersey, United States
SectorBiotechnology
Websitekalaristx.com